[Thus MID1 represents a novel, multi-faceted player in PCa and a promising target to treat castration resistant prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE